IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech

Displaying 221 - 240 of 2155 stories.
May 10, 2014
Merck KGaA (Darmstadt, Germany) plans to invest €100 million ($137.6 million) this year in biosimilars, a new business being developed by its Merck Serono unit. In addition, Merck...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Merck-KGaA-to-invest-in-biosimilars-eyes-pharma-acquisitions_60979.html
May 8, 2014
Codexis (Redwood City, CA), a developer of biocatalysts for the pharmaceutical and fine chemical industries, reports a net loss of $6.37 million in the first quarter of 2014 compared...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Codexis-narrows-loss_60892.html
May 6, 2014
FMC today reported first-quarter net income down by about half year-on-year (YOY), to $65.6 million, or 49 cts/share, on revenues up 3%, to $942 million. Earnings excluded some charges...
http://www.chemweek.com/markets/fine_chemicals_biotech/agricultural_chemicals/FMC-earnings-fall-as-ag-results-hit-by-bad-weather_60841.html
May 6, 2014
The oral solid-dosage form (OSDF) excipients market, which is valued at nearly $2.3 billion in the United States, Europe, India, and China, is growing sustainably on a global scale...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Study-Oral-solid-dosage-form-excipients-market-growing-at-7-4-percentyear_60818.html
May 6, 2014
Cambrex reports huge fall in profits Cambrex (East Rutherford, NJ) reports a 91.2% fall in net profits for the first quarter of 2014 compared with the year-ago period, to $982,000...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-6-May-2014_60821.html
May 2, 2014
Sun Pharma (Mumbai), India’s major pharmaceuticals player, said today that it is closing its Detroit manufacturing plant as part of a consolidation. The company has not said how...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Sun-Pharma-to-close-Detroit-plant_60764.html
May 2, 2014
Cambrex (East Rutherford, NJ) reports a 91.2% fall in net profits for the first quarter of 2014 compared with the year-ago period, to $982,000. First-quarter sales decreased 11.2%, to...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambrex-reports-huge-fall-in-profits_60760.html
May 2, 2014
Pfizer announced today that it has submitted a revised written proposal to AstraZeneca to combine the two companies. The move follows consultation with major shareholders. Pfizer says...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pfizer-raises-offer-for-AstraZeneca-sends-letter-to-UK-prime-minister_60757.html
April 29, 2014
The European Union's Ombudsman has concluded that the European Food Safety Authority (EFSA; Parma, Italy) is guilty of maladministration in a case involving risk assessment as a...
http://www.chemweek.com/markets/fine_chemicals_biotech/agricultural_chemicals/European-Ombudsman-condemns-EFSA-for-maladministration_60652.html
April 29, 2014
Demand growth boosts Lonza’s first-quarter performance Lonza, in its business update announcement for the first quarter of 2014, says that the year started with good momentum...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-29-April-2014_60649.html
April 28, 2014
Compass Minerals today reported net earnings up 8% year-on-year (YOY), to $50.2 million, or $1.49/share, on sales up 10%, to $422 million. Earnings beat analysts’ consensus...
http://www.chemweek.com/markets/fine_chemicals_biotech/agricultural_chemicals/Compass-Minerals-sales-earnings-rise-on-strong-demand-for-salt-and-fertilizer_60647.html
April 28, 2014
President Barack Obama, standing right, and Malaysian prime minister Najib Razak, standing left, applaud as Bill Radany, president & CEO of Verdezyne, right; and Tan Sri Dato' Seri...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Malaysian-palm-oil-giant-Sime-Darby-invests-in-Verdezyne_60635.html
April 24, 2014
SAFC Commercial, the custom-manufacturing and services business unit of Sigma-Aldrich, reports a 2.6% increase in sales in the first quarter of 2014 compared with the year-ago quarter...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/SAFC-reports-slight-increase-in-first-quarter-sales_60519.html
April 22, 2014
UK press over the weekend said that Pfizer has made initial approaches to acquire AstraZeneca for £60 billion ($101 billion) in the world’s largest pharma acquisition. Both...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pfizer-eyes-AstraZeneca-for-a-reported-$100-billion_60445.html
April 22, 2014
SI Group to acquire Albemarle’s ibuprofen business SI Group (Schenectady, NY) has agreed to acquire the antioxidant, ibuprofen, and propofol businesses of Albemarle for an...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-22-April-2014_60456.html
April 21, 2014
Platform Specialty Products (PSP; Waterbury, CT) has entered into a definitive agreement to acquire Chemtura's pesticides business for $1 billion. The price consists of $950...
http://www.chemweek.com/markets/fine_chemicals_biotech/agricultural_chemicals/Platform-acquires-Chemturas-pesticides-business-for-$1-billion_60358.html
April 16, 2014
SI Group (Schenectady, NY) has agreed to acquire the antioxidant, ibuprofen and propofol businesses of Albemarle for an undisclosed amount of cash. The deal includes manufacturing...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/SI-Group-to-acquire-Albemarles-antioxidants-and-ibuprofen-business_60349.html
April 16, 2014
Albemarle today reported net income down 32.6% year-on-year (YOY), to $56.6 million, or 71 cts/share, on net sales up 2.3%, to $656.7 million. Net income fell primarily due to charges...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Albemarle-earnings-fall-but-beat-estimates_60350.html
April 16, 2014
Syngenta had $4.7 billion in sales during the first quarter, according to the company's latest trading statement, released today. The figure represents a 2% increase from the same...
http://www.chemweek.com/markets/fine_chemicals_biotech/agricultural_chemicals/Syngentas-first-quarter-sales-up-2-percent-to-$4-7-billion_60322.html
Pages: « Previous  3 4 5 6 7 8 9 10 11 [12] 13 14 15 16 17 18 19 20 21 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa